Mammography rates 3 years after the 2009 US preventive services task force guidelines changes

Journal of Clinical Oncology

Volumn 33, Issue 9, 2015, Pages 1067-1074

  Wharam, J Frank ^a,b   Landon, Bruce ^a   Zhang, Fang ^a   Xu, Xin ^a   Soumerai, Stephen ^a   Ross Degnan, Dennis ^a  

^a HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER PREVENTION; CANCER SCREENING; CONFERENCE PAPER; ETHNICITY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAMMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; BREAST NEOPLASMS; ETHNIC GROUP; ETHNOLOGY; HEALTH INSURANCE; MIDDLE AGED; PREVENTIVE MEDICINE; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; STANDARDS; UTILIZATION;

ADULT; AGED; BREAST NEOPLASMS; ETHNIC GROUPS; FEMALE; HUMANS; INSURANCE, HEALTH; MAMMOGRAPHY; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE MEDICINE; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 84927589634     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.9848     Document Type: Conference Paper

References (54)

1. Centers for Disease Control and Prevention: 2006-2010 top ten cancers. National Program of Cancer Registries 2014. http://apps.nccd.cdc.gov/ uscs/toptencancers.aspx
2. Tabar L, Fagerberg CJ, Gad A, et al: Reduction in mortality from breast cancer after mass screening with mammography: Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829-832, 1985
3. Roberts MM, Alexander FE, Anderson TJ, et al: Edinburgh trial of screening for breast cancer: Mortality at seven years. Lancet 335:241-246, 1990
4. Andersson I, Aspegren K, Janzon L, et al: Mammographic screening and mortality from breast cancer: The Malmo mammographic screening trial. BMJ 297:943-948, 1988
5. Cronin KA, Feuer EJ, Clarke LD, et al: Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: Comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr 36:112-121, 2006
6. Berry DA, Cronin KA, Plevritis SK, et al: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784-1792, 2005
7. Christensen LH, Engholm G, Cortes R, et al: Reduced mortality for women with mammographydetected breast cancer in east Denmark and south Sweden. Eur J Cancer 42:2773-2780, 2006
8. Hershman DL, Shao T, Kushi LH, et al: Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529-537, 2011
9. Laara E, Day NE, Hakama M: Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet 1:1247-1249, 1987
10. Eddy DM: Screening for cervical cancer. Ann Intern Med 113:214-226, 1990
11. Gotzsche PC, Jorgensen KJ: Screening for breast cancer with mammography. Cochrane Database Syst Rev 6:CD001877, 2013
12. Miller AB, Wall C, Baines CJ, et al: Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomised screening trial. BMJ 348:g366, 2014
13. Hendrick RE, Helvie MA: United States Preventive Services Task Force screening mammography recommendations: Science ignored. AJR Am J Roentgenol 196:W112-W116, 2011
14. Kopans DB: The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: The scientific support for mammography screening. Radiol Clin North Am 48:843-857, 2010
15. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 151:716-726, 2009
16. Bleyer A, Welch HG: Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367:1998-2005, 2012
17. Kalager M, Adami HO, Bretthauer M, et al: Overdiagnosis of invasive breast cancer due to mammography screening: Results from the Norwegian screening program. Ann Intern Med 156:491-499, 2012
18. Gross CP, Long JB, Ross JS, et al: The cost of breast cancer screening in the Medicare population. JAMA Intern Med 173:220-226, 2013
19. US Preventive Services Taskforce: Screening for breast cancer: Recommendations and rationale. Ann Intern Med 137:344-346, 2002
20. Bevers TB, Anderson BO, Bonaccio E, et al: NCCN clinical practice guidelines in oncology: Breast cancer screening and diagnosis. J Natl Compr Canc Netw 7:1060-1096, 2009
21. Smith RA, Saslow D, Sawyer KA, et al: American Cancer Society guidelines for breast cancer screening: Update 2003. CA Cancer J Clin 53:141-169, 2003
22. American College of Obstetricians-Gynecologists: Practice bulletin no. 122: Breast cancer screening. Obstet Gynecol 118:372-382, 2011
23. American Medical Association: AMA adopts new policies at annual meeting. 2012. http://www.amaassn. org/ama/pub/news/news/2012-06-19-ama-adopts-new-policies.page
24. American College of Radiology: ACR Appropriateness Criteria? breast cancer screening. http:// www.acr.org/-/media/ACR/Documents/AppCriteria/ Diagnostic/BreastCancerScreening.pdf
25. Association of European Cancer Leagues: EU Council Recommendation on Cancer Screening. http:// www.europeancancerleagues.org/cancer-in-europe/ resources-on-cancer-in-europe/82-eu-council-recommendation-on-cancer-screening.html
26. Canadian Task Force on Preventive Health Care: Screening for breast cancer: Summary of recommendations for clinicians and policy-makers. http:// canadiantaskforce.ca/guidelines/2011-breast-cancer/
27. Kolata G: Panel urges mammograms at 50, not 40. New York Times, 2009. http://www.nytimes.com/ 2009/11/17/health/17cancer.html?-r=0
28. Stein R: Federal panel recommends reducing number of mammograms. Washington Post, 2009. http://www.washingtonpost.com/wp-dyn/content/ article/2009/11/16/AR2009111602822.html
29. Wang SS: Breast-screening advice is upended. Wall Street Journal, 2009. http://online.wsj.com/news/ articles/SB100014240527487045384045745399 71868397840
30. Dellorto D: Task force opposes routine mammograms for women age 40-49. http://www.cnn.com/ 2009/HEALTH/11/16/mammography.recommendation .changes/index.html?eref-rss-latest
31. Howard DH, Adams EK: Mammography rates after the 2009 US Preventive Services Task Force breast cancer screening recommendation. Prev Med 55:485-487, 2012
32. Pace LE, He Y, Keating NL: Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119:2518-2523, 2013
33. Sprague BL, Bolton KC, Mace JL, et al: Registry-based Study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology 270:354-361, 2014
34. Sharpe RE Jr, Levin DC, Parker L, et al: The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography. J Am Coll Radiol 10:21-24, 2013
35. Optum: Clinformatics Data Mart. http:// www.optum.com/content/dam/optum/resources/ productSheets/Clinformatics-Data-Mart.pdf
36. National Committee for Quality Assurance: HEDIS® 2014: Healthcare Effectiveness Data and Information Set. http://www.ncqa.org/Portals/0/HEDISQM/ HEDIS2014/List-of-HEDIS-2014-Measures.pdf
37. Ethnic Technologies: Homepage. http://www. ethnictechnologies.com
38. Fiscella K, Fremont AM: Use of geocoding and surname analysis to estimate race and ethnicity. Health Serv Res 41:1482-1500, 2006
39. Krieger N, Chen JT, Waterman PD, et al: Race/ethnicity, gender, and monitoring socioeconomic gradients in health: A comparison of areabased socioeconomic measures-The public health disparities geocoding project. Am J Public Health 93:1655-1671, 2003
40. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 73:13-22, 1986
41. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
42. Li Z, Mahendra G: SAS Global Forum 2010. http:// support.sas.com/resources/papers/proceedings10/272-2010.pdf.
43. Fenton JJ, Zhu W, Balch S, et al: Distinguishing screening from diagnostic mammograms using Medicare claims data. Med Care 52:e44-e51, 2014
44. National Cancer Institute: Surveillance, Epidemiology, and End Results: Fast stats: Age-adjusted rates by data type female breast, ages 50-64, 1992-2010. http:// seer.cancer.gov/faststats/selections.php?#Output
45. Miller AM, Champion VL: Attitudes about breast cancer and mammography: Racial, income, and educational differences. Women Health 26:41-63, 1997
46. Breen N, Gentleman JF, Schiller JS: Update on mammography trends: Comparisons of rates in 2000, 2005, and 2008. Cancer 117:2209-2218, 2011
47. Zhou J, Enewold L, Peoples GE, et al: Trends in cancer screening among Hispanic and white non-Hispanic women, 2000-2005. J Womens Health (Larchmt) 19:2167-2174, 2010
48. National Committee for Quality Assurance: HEDIS 2013. http://www.ncqa.org/HEDISQualityMeasurement/ HEDISMeasures/HEDIS2013.aspx
49. Centers for Medicare and Medicaid Services: Accountable Care Organization 2013 Program Analysis: Quality Performance Standards Narrative Measure Specifications. http://www.michiganpioneeraco.com/upload/ docs/2013-ACO-NarrativeMeasureSpecs.pdf
50. US Department of Health and Human Services: Healthy People 2020. http://www.healthy people.gov/2020/topicsobjectives2020/default.aspx
51. Wang AT, Fan J, Van Houten HK, et al: Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s. PLoS One 9:e91399, 2014
52. Njai R, Siegel PZ, Miller JW, et al: Misclassification of survey responses and black-white disparity in mammography use, Behavioral Risk Factor Surveillance System, 1995-2006. Prev Chronic Dis 8:A59, 2011
53. Shadish WR, Cook TD, Campbell DT: Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Boston, MA, Houghton Mifflin, 2001
54. Higgins JPT, Green S, Cochrane Collaboration: Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ, Wiley-Blackwell, 2008